GB Sciences Company Profile (OTCMKTS:GBLX)

About GB Sciences (OTCMKTS:GBLX)

GB Sciences logoGB Sciences, Inc., formerly Growblox Sciences, Inc., is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a range of ailments. It intends to conduct its business operations, through its subsidiaries in approximately three operating units, which include Solutions, Sciences and Product divisions. The Solutions division involves the development and use of its suite of controlled-climate indoor agricultural technology growing and cultivation Suites, including TissueBLOX, GrowBLOX, CureBLOX and ExtractionLAB. The Science division is engaged in preclinical testing of its biopharmaceutical cannabinoid product prototypes to begin future human clinical trials.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:GBLX
  • CUSIP: N/A
  • Web:
  • Market Cap: $28.74 million
  • Outstanding Shares: 127,746,000
Average Prices:
  • 50 Day Moving Avg: $0.25
  • 200 Day Moving Avg: $0.27
  • 52 Week Range: $0.21 - $0.65
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $54,099.00
  • Price / Sales: 531.30
  • Book Value: $0.06 per share
  • Price / Book: 3.95
  • EBITDA: ($10,010,000.00)
  • Net Margins: -5,761.07%
  • Return on Equity: -158.06%
  • Return on Assets: -100.57%
  • Average Volume: 216,165 shs.

Frequently Asked Questions for GB Sciences (OTCMKTS:GBLX)

What is GB Sciences' stock symbol?

GB Sciences trades on the OTCMKTS under the ticker symbol "GBLX."

How were GB Sciences' earnings last quarter?

GB Sciences Inc (OTCMKTS:GBLX) posted its earnings results on Monday, November, 14th. The company reported ($0.04) earnings per share for the quarter. GB Sciences had a negative return on equity of 158.06% and a negative net margin of 5,761.07%. View GB Sciences' Earnings History.

Who are some of GB Sciences' key competitors?

Who are GB Sciences' key executives?

GB Sciences' management team includes the folowing people:

  • John Poss, Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer
  • Leslie Bocskor, Independent Vice Chairman of the Board
  • Ksenia Griswold, Chief Financial Officer, Vice President
  • Andrea Small-Howard Ph.D., Chief Science Officer, Director
  • Shane Terry, Independent Director

How do I buy GB Sciences stock?

Shares of GB Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is GB Sciences' stock price today?

One share of GB Sciences stock can currently be purchased for approximately $0.23.

MarketBeat Community Rating for GB Sciences (OTCMKTS GBLX)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about GB Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for GB Sciences (OTCMKTS:GBLX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for GB Sciences (OTCMKTS:GBLX)
Price Target History for GB Sciences (OTCMKTS:GBLX)
Analysts' Ratings History for GB Sciences (OTCMKTS:GBLX)
No equities research coverage for this company has been tracked by


Earnings History for GB Sciences (OTCMKTS:GBLX)
Earnings by Quarter for GB Sciences (OTCMKTS:GBLX)
Earnings History by Quarter for GB Sciences (OTCMKTS GBLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016Q2 2017($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for GB Sciences (OTCMKTS:GBLX)

No earnings estimates for this company have been tracked by


Dividend History for GB Sciences (OTCMKTS:GBLX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for GB Sciences (OTCMKTS:GBLX)
Insider Trades by Quarter for GB Sciences (OTCMKTS:GBLX)
Insider Trades by Quarter for GB Sciences (OTCMKTS:GBLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/4/2017Craig EllinsInsiderSell100,000$0.26$26,000.00View SEC Filing  
10/6/2016Lazarus Management Co LlcMajor ShareholderSell785,000$0.31$243,350.00View SEC Filing  
10/8/2014Lazarus Management Co LlcMajor ShareholderBuy77,700$0.69$53,613.00View SEC Filing  
10/2/2014Lazarus Management Co LlcMajor ShareholderBuy39,605$0.85$33,664.25View SEC Filing  
9/29/2014Lazarus Management Co LlcMajor ShareholderBuy64,000$0.90$57,600.00View SEC Filing  
9/17/2014Lazarus Management Co LlcMajor ShareholderBuy47,640$0.76$36,206.40View SEC Filing  
8/27/2014Israel Opportunities F LazarusMajor ShareholderBuy46,625$1.05$48,956.25View SEC Filing  
8/1/2014Israel Opportunities F LazarusMajor ShareholderBuy39,800$1.24$49,352.00View SEC Filing  
7/30/2014Israel Opportunities F LazarusMajor ShareholderBuy87,077$1.24$107,975.48View SEC Filing  
7/2/2014Lazarus Investment Partners LlMajor ShareholderBuy269,632$1.19$320,862.08View SEC Filing  
6/2/2014Lazarus Management Co LlcMajor ShareholderBuy1,000,000$0.50$500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for GB Sciences (OTCMKTS:GBLX)
Latest Headlines for GB Sciences (OTCMKTS:GBLX)
Loading headlines, please wait.



GB Sciences (GBLX) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.